Charles River Laboratories CRL Unrecognized Tax Benefits
Unrecognized Tax Benefits at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
For the three months ended June 27, 2026, the Company’s unrecognized tax benefits increased by $0.1 million to $158.2 million, primarily due to increases from acquisitions, offset by decreases from divestitures. For the three months ended June 27, 2026, the amount of unrecognized income tax benefits that would impact the effective tax rate increased by $0.1 million to $153.3 million for the same reasons discussed above. The accrued interest and penalties on unrecognized tax benefits were $32.7 million and $34.2 million, respectively, as of June 27, 2026.
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's unrecognized tax benefits?
- Charles River Laboratories (CRL) reported unrecognized tax benefits of $158.2M in Q2 2026.
- How has Charles River Laboratories's unrecognized tax benefits changed year-over-year?
- Charles River Laboratories's unrecognized tax benefits increased by 441.8% year-over-year, from $29.2M to $158.2M.
- What does unrecognized tax benefits mean?
- This represents the amount of tax benefits from uncertain tax positions that have not been recognized in the financial statements because they do not meet the 'more-likely-than-not' threshold. It reflects the company's exposure to potential tax audits and disputes with tax authorities. This is a key indicator of tax-related legal and financial risk.
Ask your AI about Charles River Laboratories's unrecognized tax benefits.
Connect your AI assistant and compare it to peers, right in your chat.
